Drugs / HST5040
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04732429 | Mar 2021 → Oct 2023 | methylmalonic acidemia, propionic acidemia | HemoShear Therapeutics | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HST5040 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04732429 ↗ |